5 Key Takeaways

• 1

  Cancer detection in the U.S. dropped by approximately 9% during the first year of the COVID-19 pandemic.

• 2

  The study analyzed data from 15,831,912 patients diagnosed with invasive cancer between 2000 and 2021.

• 3

  By 2021, cancer detection nearly returned to projected levels, with a minimal difference of -0.2% in incidence.

• 4

  Rural populations experienced a 4.9% lower incidence of cancer detection than expected in 2021.

• 5

  Lung, prostate, and melanoma cancers had the largest cumulative deficits in diagnosed cases during the pandemic.